Loading people...
Sander Slootweg is Managing Partner at Forbion.
Sander Slootweg is a Managing Partner and co-founder of Forbion, a life sciences venture capital firm based in the Netherlands. Before establishing Forbion in 2006, he co-founded ABN AMRO Capital Life Sciences in 2000, building on his earlier experience in buy-out investments and equity capital markets syndications. He currently serves on all investment committees for Forbion and BGV, acts as board chair for NorthSea Therapeutics, and holds a corporate board seat at Azafaros. His extensive portfolio experience includes guiding companies to the public equity markets, having previously held board positions at NewAmsterdam Pharma, Replimune, and uniQure. Additionally, he chairs the Venture Council for Invest Europe, representing the broader private markets industry body. Slootweg focuses his venture investments on pharmaceutical and medical device development, aligning financial returns with patient outcomes across the European life sciences sector.
